{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:48:24Z","timestamp":1789584504714,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study compared the clinical effects of two different lipid emulsions in premature infants with gestational age &lt;\u200932 weeks (VPI) or birth weight &lt;\u20091500\u2009g (VLBWI) to provide an evidence-based medicine basis for optimizing intravenous lipid emulsion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a prospective multicenter randomized controlled study. A total of 465 VPIs or VLBWIs, admitted to the neonatal intensive care unit of five tertiary hospitals in China from March 1, 2021 to December 31, 2021, were recruited. All subjects were randomly allocated into two groups, namely, medium-chain triglycerides\/long-chain triglycerides (MCT\/LCT) group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009231) and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009234). Clinical features, biochemical indexes, nutrition support therapy, and complications were analyzed and compared between the two groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      No significant differences were found in perinatal data, hospitalization, parenteral and enteral nutrition support between the two groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). Compared with the MCT\/LCT group, the incidence of neonates with a peak value of total bilirubin (TB)\u2009&gt;\u20095\u2009mg\/dL (84\/231 [36.4% vs. 60\/234 [25.6%]), a peak value of direct bilirubin (DB)\u2009\u2265\u20092\u2009mg\/dL (26\/231 [11.3% vs. 14\/234 [6.0%]), a peak value of alkaline phosphatase (ALP)\u2009&gt;\u2009900\u2009IU\/L (17\/231 [7.4% vs. 7\/234 [3.0%]), and a peak value of triglycerides (TG)\u2009&gt;\u20093.4\u2009mmol\/L (13\/231 [5.6% vs. 4\/234[1.7%]]) were lower in the SMOF group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Univariate analysis showed that in the subgroup analysis of &lt;\u200928 weeks, the incidence of parenteral nutrition-associated cholestasis (PNAC) and metabolic bone disease of prematurity (MBDP) were lower in the SMOF group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.043 and 0.029, respectively), whereas no significant differences were present in the incidence of PNAC and MBDP between the two groups at &gt;\u200928 weeks group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.177 and 0.991, respectively). Multivariate logistic regression analysis revealed that the incidence of PNAC (a\n                      <jats:italic>RR<\/jats:italic>\n                      : 0.38, 95% confidence interval [\n                      <jats:italic>CI<\/jats:italic>\n                      ]: 0.20\u20130.70,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002) and MBDP (a\n                      <jats:italic>RR<\/jats:italic>\n                      : 0.12, 95% CI: 0.19\u20130.81,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.029) in the SMOF group were lower than that in the MCT\/LCT group. In addition, no significant differences were recorded in the incidence of patent ductus arteriosus, feeding intolerance, necrotizing enterocolitis (Bell\u2019s stage \u2265 2), late-onset sepsis, bronchopulmonary dysplasia, intraventricular hemorrhage, periventricular leukomalacia, retinopathy of prematurity and extrauterine growth retardation between the two groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The application of mixed oil emulsion in VPI or VLBWI can reduce the risk of plasma TB\u2009&gt;\u20095\u2009mg\/dL, DB\u2009\u2265\u20092\u2009mg\/dL, ALP\u2009&gt;\u2009900 IU\/L, and TG\u2009&gt;\u20093.4\u2009mmol\/L during hospitalization. SMOF has better lipid tolerance, reduces the incidence of PNAC and MBDP, and exerts more benefits in preterm infants with gestational age &lt;\u200928 weeks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41430-023-01288-6","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:02:37Z","timestamp":1683118957000},"page":"823-832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of mixed oil emulsion on short-term clinical outcomes in premature infants: A prospective, multicenter, randomized controlled trial"],"prefix":"10.1038","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-4330","authenticated-orcid":false,"given":"Qing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Miao","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Sen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Rong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3266-228X","authenticated-orcid":false,"given":"Xin-Zhu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8564-4619","authenticated-orcid":false,"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6587-4091","authenticated-orcid":false,"given":"Zhan-Kui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8843-887X","authenticated-orcid":false,"given":"Jian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4477-4123","authenticated-orcid":false,"given":"Xiao-mei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"1288_CR1","first-page":"CD013163","volume":"6","author":"V Kapoor","year":"2019","unstructured":"Kapoor V, Malviya MN, Soll R. Lipid emulsions for parenterally fed preterm infants. Cochrane Database Syst Rev. 2019;6:CD013163.","journal-title":"Cochrane Database Syst Rev"},{"key":"1288_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000365431","volume":"112","author":"YA Carpentier","year":"2015","unstructured":"Carpentier YA, Deckelbaum RJ. In vivo handling and metabolism of lipid emulsions. World Rev Nutr Diet. 2015;112:57\u201362.","journal-title":"World Rev Nutr Diet"},{"key":"1288_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0884533612462900","volume":"28","author":"EM Tillman","year":"2013","unstructured":"Tillman EM. Review and clinical update on parenteral nutrition-associated liver disease. Nutr Clin Pract. 2013;28:30\u201339.","journal-title":"Nutr Clin Pract"},{"key":"1288_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0148607103027003225","volume":"27","author":"E Vinnars","year":"2003","unstructured":"Vinnars E, Wilmore D. nathan roads symposium papers. History of parenteral nutrition. JPEN J Parenter Enteral Nutr. 2003;27:225\u201331.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1288_CR5","doi-asserted-by":"publisher","first-page":"206ra137","DOI":"10.1126\/scitranslmed.3006898","volume":"5","author":"KC El Kasmi","year":"2013","unstructured":"El Kasmi KC, Anderson AL, Devereaux MW, Vue PM, Zhang W, Setchell KD, et al. Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease. Sci Transl Med. 2013;5:206ra137.","journal-title":"Sci Transl Med"},{"key":"1288_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/0148607106030004351","volume":"30","author":"DL Waitzberg","year":"2006","unstructured":"Waitzberg DL, Torrinhas RS, Jacintho TM. New parenteral lipid emulsions for clinical use. JPEN J Parenter Enteral Nutr. 2006;30:351\u201367.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1288_CR7","first-page":"782","volume":"34","author":"W Cai","year":"2013","unstructured":"Group of Pediatrics, Parenteral and Enteral Nutrition Society, Chinese Medical Association; Group of Neonatology, Pediatric Society, Chinese Medical Association; Group of Neonatology, Pediatric Surgical Society, Chinese Medical Association, Cai W, Tang QY, Feng Y. Chinese guideline for newborn nutrition support in neonates. Chinese J Pediatr Surg. 2013;34:782\u20137.","journal-title":"Chinese J Pediatr Surg"},{"key":"1288_CR8","unstructured":"U.S. Food and Drug Administration. CY 2016 CDER Drug and Biologic Calendar Year Approvals. 2016. https:\/\/www.fda.gov\/media\/102962\/download."},{"key":"1288_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.jp.7211686","volume":"27","author":"RD Christensen","year":"2007","unstructured":"Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol. 2007;27:284\u201390.","journal-title":"J Perinatol"},{"key":"1288_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/0884533616687532","volume":"32","author":"W Yan","year":"2017","unstructured":"Yan W, Hong L, Wang Y, Feng Y, Lu L, Tao Y, et al. Retrospective dual-center study of parenteral nutrition-associated cholestasis in premature neonates: 15 Years\u2019 Experience. Nutr Clin Pract. 2017;32:407\u201313.","journal-title":"Nutr Clin Pract"},{"key":"1288_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13052-015-0178-7","volume":"41","author":"C Dani","year":"2015","unstructured":"Dani C, Pratesi S, Raimondi F, Romagnoli C. Task force for hyperbilirubinemia of the Italian society of neonatology. Italian guidelines for the management and treatment of neonatal cholestasis. Ital J Pediatr. 2015;41:69.","journal-title":"Ital J Pediatr"},{"key":"1288_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","volume":"200","author":"EA Jensen","year":"2019","unstructured":"Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019;200:751\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1288_CR13","first-page":"1835","volume":"28","author":"Neonatal Pediatrician Branch of Chinese Medical Association.","year":"2013","unstructured":"Neonatal Pediatrician Branch of Chinese Medical Association. Guidelines for oxygen and prevention and treatment of retinopathy in premature infants (revised). Chinese J Appl Clin Pediatrics. 2013;28:1835\u20136.","journal-title":"Chinese J Appl Clin Pediatrics"},{"key":"1288_CR14","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1288_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/ANC.0b013e31821ba28e","volume":"11","author":"TA Moore","year":"2011","unstructured":"Moore TA, Wilson ME. Feeding intolerance: a concept analysis. Adv Neonatal Care. 2011;11:149\u201354.","journal-title":"Adv Neonatal Care"},{"key":"1288_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2431-13-59","volume":"13","author":"TR Fenton","year":"2013","unstructured":"Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:59.","journal-title":"BMC Pediatr"},{"key":"1288_CR17","first-page":"252","volume":"57","author":"Department of Neonatology, science branch, Chinese Medical Association; Infection Committee of neonatal pediatricians branch, Chinese Medical Association.","year":"2019","unstructured":"Department of Neonatology, science branch, Chinese Medical Association; Infection Committee of neonatal pediatricians branch, Chinese Medical Association. Expert consensus on diagnosis and treatment of neonatal sepsis (2019 Edition). Chinese J Pediatr. 2019;57:252\u20137.","journal-title":"Chinese J Pediatr"},{"key":"1288_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1651-2227.2000.tb00395.x","volume":"89","author":"MC Backstr\u00f6m","year":"2000","unstructured":"Backstr\u00f6m MC, Kouri T, Kuusela AL, Siev\u00e4nen H, Koivisto AM, Ikonen RS, et al. Bone isoenzyme of serum alkaline phosphatase and serum inorganic phosphate in metabolic bone disease of prematurity. Acta Paediatr. 2000;89:867\u201373.","journal-title":"Acta Paediatr"},{"key":"1288_CR19","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1542\/peds.2004-1699","volume":"116","author":"AL Patel","year":"2005","unstructured":"Patel AL, Engstrom JL, Meier PP, Kimura RE. Accuracy of methods for calculating postnatal growth velocity for extremely low birth weight infants. Pediatrics. 2005;116:1466\u201373.","journal-title":"Pediatrics."},{"key":"1288_CR20","unstructured":"Shao XM, Ye HM, Qiu XS. Practical neonatology, 5rd ed. Beijing, 2019: People\u2019s Health Press, China pp. 575,632,855,860."},{"key":"1288_CR21","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1002\/jpen.1759","volume":"44","author":"GC Deshpande","year":"2020","unstructured":"Deshpande GC, Cai W. Use of Lipids in Neonates Requiring Parenteral Nutrition. JPEN J Parenter Enteral Nutr. 2020;44:S45\u2013S54.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1288_CR22","first-page":"755","volume":"23","author":"Q Yang","year":"2021","unstructured":"Yang Q, Lin XZ. Research advances in the effect of long-chain polyunsaturated fatty acids on neonates. Zhongguo Dang Dai Er Ke Za Zhi. 2021;23:755\u201360.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"1288_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1542\/peds.2014-0459","volume":"134","author":"P Zhang","year":"2014","unstructured":"Zhang P, Lavoie PM, Lacaze-Masmonteil T, Rhainds M, Marc I. Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review. Pediatrics. 2014;134:120\u201334.","journal-title":"Pediatrics."},{"key":"1288_CR24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/mnfr.200600308","volume":"51","author":"M Fit\u00f3","year":"2007","unstructured":"Fit\u00f3 M, de la Torre R, Covas MI. Olive oil and oxidative stress. Mol Nutr Food Res. 2007;51:1215\u201324.","journal-title":"Mol Nutr Food Res"},{"key":"1288_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/0148607115621863","volume":"40","author":"SA McClave","year":"2016","unstructured":"McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40:159\u2013211.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1288_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/0884217504272805","volume":"34","author":"K Gregory","year":"2005","unstructured":"Gregory K. Update on nutrition for preterm and full-term infants. J Obstet Gynecol Neonatal Nurs. 2005;34:98\u2013108.","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"1288_CR27","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41372-019-0425-7","volume":"39","author":"R Torgalkar","year":"2019","unstructured":"Torgalkar R, Dave S, Shah J, Ostad N, Kotsopoulos K, Unger S, et al. Multi-component lipid emulsion vs soy-based lipid emulsion for very low birth weight preterm neonates: A pre-post comparative study. J Perinatol. 2019;39:1118\u201324.","journal-title":"J Perinatol"},{"key":"1288_CR28","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.clnu.2018.06.946","volume":"37","author":"A Lapillonne","year":"2018","unstructured":"Lapillonne A, Fidler Mis N, Goulet O, van den Akker CHP, Wu J, Koletzko B. ESPGHAN\/ESPEN\/ESPR\/CSPEN working group on pediatric parenteral nutrition. ESPGHAN\/ESPEN\/ESPR\/CSPEN guidelines on pediatric parenteral nutrition: Lipids. Clin Nutr. 2018;37:2324\u201336.","journal-title":"Clin Nutr"},{"key":"1288_CR29","first-page":"254","volume":"15","author":"YH Li","year":"2013","unstructured":"Li YH, Wang XL. Risk factors for parenteral nutrition-associated cholestasis in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi. 2013;15:254\u20138.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"1288_CR30","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1055\/s-0038-1676977","volume":"36","author":"Y Kasirer","year":"2019","unstructured":"Kasirer Y, Bin-Nun A, Raveh A, Schorrs I, Mimouni FB, Hammerman C. SMOFlipid Protects Preterm Neonates against Perinatal Nutrition-Associated Cholestasis. Am J Perinatol. 2019;36:1382\u20136.","journal-title":"Am J Perinatol"},{"key":"1288_CR31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/MPG.0b013e3181de210c","volume":"1","author":"E Tomsits","year":"2010","unstructured":"Tomsits E, Pataki M, T\u00f6lgyesi A, Fekete G, Rischak K, Szoll\u00e1r L. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010;1:514\u201321.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1288_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clnesp.2017.08.007","volume":"22","author":"L Pereira-da-Silva","year":"2017","unstructured":"Pereira-da-Silva L, N\u00f3brega S, Rosa ML, Alves M, Pita A, Virella D, et al. Parenteral nutrition-associated cholestasis and triglyceridemia in surgical term and near-term neonates: A pilot randomized controlled trial of two mixed intravenous lipid emulsions. Clin Nutr ESPEN. 2017;22:7\u201312.","journal-title":"Clin Nutr ESPEN"},{"key":"1288_CR33","first-page":"181","volume":"88","author":"S Putadechakum","year":"2005","unstructured":"Putadechakum S, Tanphaichitr V, Leelahagul P, Pakpeankitvatana V, Surapisitchart T, Komindr S. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients. J Med Assoc Thai. 2005;88:181\u20136.","journal-title":"J Med Assoc Thai"},{"key":"1288_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1194\/jlr.M200282-JLR200","volume":"44","author":"Y Park","year":"2003","unstructured":"Park Y, Harris WS. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res. 2003;44:455\u201363.","journal-title":"J Lipid Res"},{"key":"1288_CR35","first-page":"761","volume":"23","author":"YM Chen","year":"2021","unstructured":"Chen YM, Lin XZ, Zhang R, Liu XH, Tong XM, Chen PY, et al. Nutritional Committee of Neonatology Branch of Chinese Medical Doctor Association; Neonatal Nutrition and Health Management Group, Professional Committee of Child Health; et al. Expert consensus on clinical management of metabolic bone disease of prematurity (2021). Zhongguo Dang Dai Er Ke Za Zhi. 2021;23:761\u201372.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"1288_CR36","doi-asserted-by":"publisher","first-page":"101069","DOI":"10.1016\/j.siny.2019.101069","volume":"25","author":"EV Schulz","year":"2020","unstructured":"Schulz EV, Wagner CL. History, epidemiology and prevalence of neonatal bone mineral metabolic disorders. Semin Fetal Neonatal Med. 2020;25:101069.","journal-title":"Semin Fetal Neonatal Med"},{"key":"1288_CR37","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/0884533612454547","volume":"27","author":"M Skouroliakou","year":"2012","unstructured":"Skouroliakou M, Konstantinou D, Agakidis C, Delikou N, Koutri K, Antoniadi M, et al. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT\/\u03c9-3-PUFA-containing or soybean-based lipid emulsions. Nutr Clin Pract. 2012;27:817\u201324.","journal-title":"Nutr Clin Pract"},{"key":"1288_CR38","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.clnu.2014.01.009","volume":"33","author":"R D\u2019Ascenzo","year":"2014","unstructured":"D\u2019Ascenzo R, Savini S, Biagetti C, Bellagamba MP, Marchionni P, Pompilio A, et al. Higher docosahexaenoic acid, lower arachidonic acid and reduced lipid tolerance with high doses of a lipid emulsion containing 15% fish oil: a randomized clinical trial. Clin Nutr. 2014;33:1002\u20139.","journal-title":"Clin Nutr"},{"key":"1288_CR39","doi-asserted-by":"publisher","first-page":"e0269180","DOI":"10.1371\/journal.pone.0269180","volume":"17","author":"J Wang","year":"2022","unstructured":"Wang J, Zhao Q, Chen B, Sun J, Huang J, Meng J, et al. Risk factors for metabolic bone disease of prematurity: A meta-analysis. PLoS One. 2022;17:e0269180.","journal-title":"PLoS One"},{"key":"1288_CR40","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00198-012-2138-z","volume":"24","author":"A Casado-D\u00edaz","year":"2013","unstructured":"Casado-D\u00edaz A, Santiago-Mora R, Dorado G, Quesada-G\u00f3mez JM. The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis. Osteoporos Int. 2013;24:1647\u201361.","journal-title":"Osteoporos Int"},{"key":"1288_CR41","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.plipres.2010.06.002","volume":"49","author":"MC Kruger","year":"2010","unstructured":"Kruger MC, Coetzee M, Haag M, Weiler H. Long-chain polyunsaturated fatty acids: selected mechanisms of action on bone. Prog Lipid Res. 2010;49:438\u201349.","journal-title":"Prog Lipid Res"},{"key":"1288_CR42","doi-asserted-by":"publisher","first-page":"589641","DOI":"10.1155\/2013\/589641","volume":"2013","author":"N Kajarabille","year":"2013","unstructured":"Kajarabille N, D\u00edaz-Castro J, Hijano S, L\u00f3pez-Fr\u00edas M, L\u00f3pez-Aliaga I, Ochoa JJ. A new insight to bone turnover: role of \u03c9-3 polyunsaturated fatty acids. ScientificWorldJournal. 2013;2013:589641.","journal-title":"ScientificWorldJournal."},{"key":"1288_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pedneo.2019.01.003","volume":"60","author":"CY Yeung","year":"2019","unstructured":"Yeung CY. Fat-soluble vitamin deficiency in pediatric patients with chronic liver disease. Pediatr Neonatol. 2019;60:1\u20132.","journal-title":"Pediatr Neonatol"},{"key":"1288_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.maturitas.2020.05.020","volume":"140","author":"A Capozzi","year":"2020","unstructured":"Capozzi A, Scambia G, Lello S. Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health. Maturitas. 2020;140:55\u201363.","journal-title":"Maturitas."},{"key":"1288_CR45","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/nu12071909","volume":"12","author":"N Tsugawa","year":"2020","unstructured":"Tsugawa N, Shiraki M. Vitamin K Nutrition and Bone Health. Nutrients. 2020;12:1909.","journal-title":"Nutrients."},{"key":"1288_CR46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/jpen.2229","volume":"46","author":"S Chen","year":"2022","unstructured":"Chen S, Xiao Y, Liu Y, Tian X, Wang W, Jiang L, et al. Fish oil-based lipid emulsion alleviates parenteral nutrition-associated liver diseases and intestinal injury in piglets. JPEN J Parenter Enteral Nutr. 2022;46:709\u201320.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1288_CR47","doi-asserted-by":"publisher","first-page":"e1901269","DOI":"10.1002\/mnfr.201901269","volume":"65","author":"P Wawrzyniak","year":"2021","unstructured":"Wawrzyniak P, Noureddine N, Wawrzyniak M, Lucchinetti E, Kr\u00e4mer SD, Rogler G, et al. Nutritional Lipids and Mucosal Inflammation. Mol Nutr Food Res. 2021;65:e1901269.","journal-title":"Mol Nutr Food Res"},{"key":"1288_CR48","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.clnu.2018.06.929","volume":"38","author":"CC Hsiao","year":"2019","unstructured":"Hsiao CC, Lin HC, Chang YJ, Yang SP, Tsao LY, Lee CH, et al. Intravenous fish oil containing lipid emulsion attenuates inflammatory cytokines and the development of bronchopulmonary dysplasia in very premature infants: A double-blind, randomized controlled trial. Clin Nutr. 2019;38:1045\u201352.","journal-title":"Clin Nutr"},{"key":"1288_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jpeds.2017.11.012","volume":"194","author":"A Repa","year":"2018","unstructured":"Repa A, Binder C, Thanhaeuser M, Kreissl A, Pablik E, Huber-Dangl M, et al. A Mixed Lipid Emulsion for Prevention of Parenteral Nutrition Associated Cholestasis in Extremely Low Birth Weight Infants: A Randomized Clinical Trial. J Pediatr. 2018;194:87\u201393.","journal-title":"J Pediatr"},{"key":"1288_CR50","first-page":"229","volume":"23","author":"HJ Lin","year":"2021","unstructured":"Lin HJ, Shen XX, Ni YH, Ma XL, Shi LL, Du LZ. Efficacy analysis of multiple oil fat emulsions in ultra-low birth weight infants. Zhongguo Dang Dai Er Ke Za Zhi. 2021;23:229\u201335.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"1288_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12887-022-03174-9","volume":"22","author":"R Yang","year":"2022","unstructured":"Yang R, Ding H, Shan J, Li X, Zhang J, Liu G, et al. Association of fish oil containing lipid emulsions with retinopathy of prematurity: A retrospective observational study. BMC Pediatr. 2022;22:113.","journal-title":"BMC Pediatr"},{"key":"1288_CR52","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1055\/s-0039-1692390","volume":"37","author":"A Bin-Nun","year":"2020","unstructured":"Bin-Nun A, Kassirer Y, Mimouni FB, Shchors I, Hammerman C. Head Circumference Growth Is Enhanced by SMOFlipid in Preterm Neonates. Am J Perinatol. 2020;37:1130\u20133.","journal-title":"Am J Perinatol"}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41430-023-01288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41430-023-01288-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41430-023-01288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T19:15:20Z","timestamp":1702322120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41430-023-01288-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1038\/s41430-023-01288-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1926499\/v1","asserted-by":"object"}]},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,3]]},"assertion":[{"value":"3 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study is registered with the Chinese clinical trial registry (\n                      \n                      ), registration number: ChiCTR210041910. The study was approved by the Ethics Committee of Women and Children\u2019s Hospital, School of Medicine, Xiamen University (2021-01-08, KY-2020\u20130086\u201301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}